Vertex Pharmaceuticals (VRTX) announced that Health Canada has granted Marketing Authorization for ALYFTREK, a new triple combination therapy for ...

Vertex Pharmaceuticals today announced that Health Canada has granted Marketing Authorization for PrALYFTREKTM (vanzacaftor/tezacaftor/deutivacaftor), a new triple combination therapy for patients ...

War, what is it good for? Not much – but military conflict has historically fuelled the development of technology that’s now ...

Video webcast now available on-demand LA JOLLA, CA, July 22, 2025 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” ...

CB03-154 is a newer ALS therapy that's designed to open nerve cells' KCNQ2 and KCNQ3 potassium channels without affecting ...

AC Immune SA has synthesized new heterocyclic modulators acting as NLRP3 inflammasome inhibitors. As such, they are reported to be potentially useful for the treatment of asthma, atherosclerosis, ...

In this paper the automated high-level synthesis of subsampling continuous-time bandpass ΣΔ modulators including non-idealities is described. State-of-the-art design methodologies for bandpass ΣΔ ...

Researchers in Canada have developed an optical chip that harnesses the power of light to transfer data at unprecedented speed.

A hair-thin optical chip transmits AI training data at 1,000 Gbps using just 4 joules of energy, offering a compact, ...

Artificial intelligence systems like ChatGPT are notorious for being power-hungry. To tackle this challenge, a team from the ...

Wim Bogaerts, Professor in Silicon Photonics at Ghent University-IMEC, Founder of Luceda Photonics, explains how the ...

Covesion, AdvR, and Radiantis are united by a shared vision: to deliver high-performance, cutting-edge solutions for the ...